• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    XPeng Posts Strong Results, Joins Larimar Therapeutics, Transcat And Other Big Stocks Moving Higher On Tuesday

    5/21/24 10:38:35 AM ET
    $BE
    $DG
    $IREN
    $LOT
    Industrial Machinery/Components
    Energy
    Department/Specialty Retail Stores
    Consumer Discretionary
    Get the next $BE alert in real time by email

    U.S. stocks were mostly higher, with the Dow Jones index gaining around 50 points on Tuesday.

    Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter results and issued second-quarter guidance.

    XPeng reported fiscal first-quarter sales growth of 62.3% year-on-year, to 6.55 billion Chinese Yuan ($0.91 billion), beating the analyst consensus estimate of 6.17 billion Chinese Yuan ($0.87 billion). Total revenues declined 49.8% sequentially. Adjusted net loss per ADS of $0.21 beat the analyst consensus loss estimate of $0.27, according to data from Benzinga Pro.

    XPeng shares jumped 10% to $9.12 on Tuesday.

    Here are some other big stocks recording gains in today's session.

    • Waldencast plc (NASDAQ:WALD) shares climbed 15% to $5.00 following first-quarter results.
    • Larimar Therapeutics, Inc.. (NASDAQ:LRMR) gained 12.3% to $8.16 after the company announced that the FDA removed the partial clinical hold previously placed on the nomlabofusp clinical program.
    • Nukkleus Inc. (NASDAQ:NUKK) surged 11.4% to $1.0299
    • Transcat, Inc. (NASDAQ:TRNS) climbed 10.1% to $136.63 following better-than-expected quarterly earnings.
    • Bloom Energy Corporation (NYSE:BE) gained 9.7% to $14.18.
    • Tandem Diabetes Care, Inc. (NASDAQ:TNDM) climbed 8.6% to $51.28.
    • Mesoblast Limited (NASDAQ:MESO) gained 8.1% to $7.90.
    • Iris Energy Limited (NASDAQ:IREN) rose 8% to $6.87.
    • Nikola Corporation (NASDAQ:NKLA) climbed 6.2% to $0.56. The company announced that AiLO Logistics, a significant drayage carrier operating in the Ports of Los Angeles and Long Beach, has placed a 100-truck order of Nikola hydrogen fuel cell electric vehicles from Tom's Truck Centers, a member of the Nikola sales and service dealer network..
    • Lotus Technology Inc. (NASDAQ:LOT) gained 6.1% to $9.06.
    • Dollar General Corporation (NYSE:DG) rose 4.4% to $143.88

    Now Read This: Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month

    Get the next $BE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BE
    $DG
    $IREN
    $LOT

    CompanyDatePrice TargetRatingAnalyst
    Bloom Energy Corporation
    $BE
    2/24/2026$162.00Neutral
    Citigroup
    Tandem Diabetes Care Inc.
    $TNDM
    2/23/2026$50.00Hold → Buy
    Lake Street
    Tandem Diabetes Care Inc.
    $TNDM
    2/20/2026$30.00Underperform → Neutral
    BofA Securities
    Dollar General Corporation
    $DG
    2/17/2026$111.00Neutral → Sell
    Rothschild & Co Redburn
    Bloom Energy Corporation
    $BE
    2/6/2026$105.00 → $160.00Hold
    TD Cowen
    Bloom Energy Corporation
    $BE
    1/28/2026$153.00Equal Weight
    Barclays
    Bloom Energy Corporation
    $BE
    1/28/2026$207.00Buy
    China Renaissance
    Tandem Diabetes Care Inc.
    $TNDM
    1/27/2026$25.00Buy
    TD Cowen
    More analyst ratings

    $BE
    $DG
    $IREN
    $LOT
    SEC Filings

    View All

    Transcat Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - TRANSCAT INC (0000099302) (Filer)

    3/9/26 4:10:55 PM ET
    $TRNS
    Electrical Products
    Industrials

    Larimar Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Larimar Therapeutics, Inc. (0001374690) (Filer)

    3/9/26 4:08:31 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by XPeng Inc.

    6-K - XPENG INC. (0001810997) (Filer)

    3/5/26 10:09:54 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    $BE
    $DG
    $IREN
    $LOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lotus Tech Launches Pre-Sales for LOTUS For Me in China

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today announced the official commencement of pre-sales for LOTUS For Me, its hyper-SUV, in the Chinese market. The new model is available in two variants with pre-sale prices starting at Rmb528,000 (approximately USD $76,800) and Rmb588,000 (approximately USD $85,500), respectively. During the launch event, Mr. Feng Qingfeng, CEO of Lotus Tech, announced that the entire lineup of LOTUS For Me will be built on Geely Afari Smart Driving (G-ASD) H7 architecture and will come standard with the NVIDIA Thor flagship computing

    3/10/26 5:00:00 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    Dollar General Unveils "7 Days of Savings" Cleaning Event Deals

    Daily offers pair with DG's everyday value initiatives, including $1 Value Valley finds, to make Spring refresh more affordable Dollar General (NYSE:DG) today announced its 7 Days of Savings cleaning event, offering customers a full week of values on trusted cleaning, home care and organizational essentials. Running March 15-21, the event features daily, limited-time deals designed to help customers refresh, reset and restock their homes for less. 7 Days of Savings cleaning event deals include: Sunday, March 15: Clorox Scentiva® Lavender Jasmine Scent Bleach 81 oz. —$4.45 Sale Monday, March 16: NEW True Living® Scented Candles (2‑ct. 6.8 oz.) — Buy One, Get One 50% Off Tuesday,

    3/10/26 6:55:00 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Transcat Appoints Jaime Irick as President and Chief Executive Officer

    Proven B2B Industrial and Technology Leader Brings Strong Track Record of Growth and Value Creation Transcat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leader in test measurement, control and calibration, today announced the appointment of Jaime Irick as President and Chief Executive Officer, effective March 29, 2026. The Board also appointed Mr. Irick to the Transcat Board of Directors as of March 29, 2026, where he will serve on the Executive Committee. As previously announced, Lee D. Rudow is retiring from his role as CEO and from the Board, and will be a senior advisor to the Company through March 2027. "Jaime is a proven C-suite executive and public company board member w

    3/9/26 4:05:00 PM ET
    $ITW
    $PPG
    $TRNS
    Industrial Machinery/Components
    Industrials
    Paints/Coatings
    Consumer Discretionary

    $BE
    $DG
    $IREN
    $LOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CHIEF COMMERCIAL OFFICER Novara Mark David sold $46 worth of shares (2 units at $22.81), decreasing direct ownership by 0.01% to 35,969 units (SEC Form 4)

    4 - TANDEM DIABETES CARE INC (0001438133) (Issuer)

    3/9/26 4:27:14 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    Chairman & CEO Sridhar Kr was granted 300,000 shares, increasing direct ownership by 14% to 2,489,869 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    3/3/26 7:24:43 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    * Director by Deputization Flynn James E bought $25,000,000 worth of shares (5,000,000 units at $5.00) (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 7:46:04 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BE
    $DG
    $IREN
    $LOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Bloom Energy with a new price target

    Citigroup initiated coverage of Bloom Energy with a rating of Neutral and set a new price target of $162.00

    2/24/26 7:46:09 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    Tandem Diabetes Care upgraded by Lake Street with a new price target

    Lake Street upgraded Tandem Diabetes Care from Hold to Buy and set a new price target of $50.00

    2/23/26 8:30:19 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    Tandem Diabetes Care upgraded by BofA Securities with a new price target

    BofA Securities upgraded Tandem Diabetes Care from Underperform to Neutral and set a new price target of $30.00

    2/20/26 8:21:03 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    $BE
    $DG
    $IREN
    $LOT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    * Director by Deputization Flynn James E bought $25,000,000 worth of shares (5,000,000 units at $5.00) (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 7:46:04 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hamilton Thomas Edward bought $500,000 worth of shares (100,000 units at $5.00), increasing direct ownership by 18% to 664,798 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:41 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Thomas Frank E bought $25,000 worth of shares (5,000 units at $5.00), increasing direct ownership by 250% to 7,000 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:36 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BE
    $DG
    $IREN
    $LOT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 28, 2025 - FDA Roundup: February 28, 2025

    For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

    2/28/25 5:00:47 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    November 7, 2023 - FDA Roundup: November 7, 2023

    For Immediate Release: November 07, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA issued a Safety Communication warning consumers, health care providers, and health care facilities not to use recalled saline (0.9% sodium chloride) and sterile water medical products manufactured by Nurse Assist, LLC. On November 6, Nurse

    11/7/23 3:38:18 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    $BE
    $DG
    $IREN
    $LOT
    Leadership Updates

    Live Leadership Updates

    View All

    IREN Appoints John Gross as Chief Innovation Officer

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN's next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data ce

    2/17/26 5:00:50 AM ET
    $IREN
    EDP Services
    Technology

    LOTUS Appoints Piano Master Lang Lang as Friend of the Brand

    NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today updated that LOTUS announced world-renowned pianist Lang Lang as its Friend of the Brand, marking a new partnership built on a shared pursuit of precision, performance, and excellence. Recognized globally for his extraordinary technique and expressive artistry, Lang Lang has brought classical music to audiences across cultures and generations. His dedication to mastery through discipline and refinement closely mirrors LOTUS's engineering philosophy, where every detail is shaped to deliver pure driving performance.

    2/6/26 8:30:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors

    Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. Ms. Beaver joins the board as an independent director and will serve on the board's Audit Committee and Cybersecurity and Data Oversight Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112460451/en/Sandra Beaver joins Tandem Diabetes Care Board of Directors. "We welcome Sandra to our Board of Directors at this pivotal stage in Tandem's evolution," said John Sheridan, president and CEO. "Sandra is a dynamic finance

    11/12/25 9:00:00 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    $BE
    $DG
    $IREN
    $LOT
    Financials

    Live finance-specific insights

    View All

    Transcat Appoints Jaime Irick as President and Chief Executive Officer

    Proven B2B Industrial and Technology Leader Brings Strong Track Record of Growth and Value Creation Transcat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leader in test measurement, control and calibration, today announced the appointment of Jaime Irick as President and Chief Executive Officer, effective March 29, 2026. The Board also appointed Mr. Irick to the Transcat Board of Directors as of March 29, 2026, where he will serve on the Executive Committee. As previously announced, Lee D. Rudow is retiring from his role as CEO and from the Board, and will be a senior advisor to the Company through March 2027. "Jaime is a proven C-suite executive and public company board member w

    3/9/26 4:05:00 PM ET
    $ITW
    $PPG
    $TRNS
    Industrial Machinery/Components
    Industrials
    Paints/Coatings
    Consumer Discretionary

    XPENG to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Friday, March 20, 2026

    - Earnings Call Scheduled for 8:00 a.m. ET on March 20, 2026 -GUANGZHOU, China, March 5, 2026 /PRNewswire/ -- XPeng Inc. ((", XPENG", or the ", Company, ", NYSE:XPEV), a leading global AI mobility technology company, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Friday, March 20, 2026, before the open of U.S. markets. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 20, 2026 (8:00 PM Beijing/Hong Kong Time on March 20, 2026).For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the

    3/5/26 4:00:00 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance

    Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its financial guidance for the year ending December 31, 2026. Fourth Quarter 2025 Financial and Strategic Highlights Achieved record quarterly sales: Worldwide sales of $290.4 million United States sales of $210.5 million Worldwide pump shipments of 38,000 United States pump shipments of 27,000 Delivered meaningful operational improvement: Record quarterly gross margin of 58% Operating income of $8.3 million, or 3% of sales Net loss of $0.6 million with posi

    2/19/26 4:05:00 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    $BE
    $DG
    $IREN
    $LOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Larimar Therapeutics Inc.

    SC 13G/A - Larimar Therapeutics, Inc. (0001374690) (Subject)

    11/14/24 5:05:19 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tandem Diabetes Care Inc.

    SC 13G/A - TANDEM DIABETES CARE INC (0001438133) (Subject)

    11/14/24 4:15:44 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care